(8S,11R,13S,14S,17R)-11-[4-(dimethylamino)phenyl]-17-hydroxy-17-(2-methoxyacetyl)-13-methyl-1,2,6,7,8,11,12,14,15,16-decahydrocyclopenta[a]phenanthren-3-one结构式
|
常用名 | (8S,11R,13S,14S,17R)-11-[4-(dimethylamino)phenyl]-17-hydroxy-17-(2-methoxyacetyl)-13-methyl-1,2,6,7,8,11,12,14,15,16-decahydrocyclopenta[a]phenanthren-3-one | 英文名 | (8S,11R,13S,14S,17R)-11-[4-(dimethylamino)phenyl]-17-hydroxy-17-(2-methoxyacetyl)-13-methyl-1,2,6,7,8,11,12,14,15,16-decahydrocyclopenta[a]phenanthren-3-one |
|---|---|---|---|---|
| CAS号 | 198414-30-1 | 分子量 | 463.60800 | |
| 密度 | N/A | 沸点 | N/A | |
| 分子式 | C29H37NO4 | 熔点 | N/A | |
| MSDS | N/A | 闪点 | N/A |
| 英文名 | (8S,11R,13S,14S,17R)-11-[4-(dimethylamino)phenyl]-17-hydroxy-17-(2-methoxyacetyl)-13-methyl-1,2,6,7,8,11,12,14,15,16-decahydrocyclopenta[a]phenanthren-3-one |
|---|---|
| 英文别名 | 更多 |
| 分子式 | C29H37NO4 |
|---|---|
| 分子量 | 463.60800 |
| 精确质量 | 463.27200 |
| PSA | 66.84000 |
| LogP | 4.59870 |
| InChIKey | BHERMCLNVOVDPU-DQFOBABISA-N |
| SMILES | COCC(=O)C1(O)CCC2C3CCC4=CC(=O)CCC4=C3C(c3ccc(N(C)C)cc3)CC21C |
|
~77%
(8S,11R,13S,14S... 198414-30-1 |
| 文献:Bodi, Jozsef; Visky, Gyoergy; Szeles, Janos; Maho, Sandor; Santa, Csaba; Csoergei, Janos; Tuba, Zoltan; Terdy, Laszlo; Molnar, Csaba; Aranyi, Antal; Horvath, Zoltan; Balogh, Gabor Patent: US2010/137622 A1, 2010 ; Location in patent: Page/Page column 12 ; |
| 上游产品 1 | |
|---|---|
| 下游产品 0 | |
| Telapristone |
| Telapristone [INN] |
| 19-Norpregna-4,9-diene-3,20-dione,17-hydroxy-11-(4-(dimethylamino)phenyl)-21-methoxy-,(11beta) |
| 11beta-(4-(dimethylamino)phenyl)-17-hydroxy-21-methoxy-19-norpregna-4,9-diene-3,20-dione |